• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Individuals with stroke three months after hospital discharge reported worse quality of life during the covid-19 pandemic
: To compare quality of life (QOL) of individuals with stroke three months after hospital discharge, using generic and specific QOL measures, before and during the COVID-19 pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - March 12, 2023 Category: Neurology Authors: Camila Lima Gerv ásio Mendes, Marcela Aline Fernandes Braga, Edvânia Andrade de Moura Silva, Aline Alvim Scianni, Luci Fuscaldi Teixeira-Salmela, Kênia Kiefer Parreiras de Menezes, Iza de Faria-Fortini, Christina Danielli Coelho de Morais Faria Source Type: research

Telemedicine Impact on Post-Stroke Outpatient Follow-up in an Academic Healthcare Network during the COVID-19 Pandemic
The objective of our study was to determine the impact of telemedicine on post-acute stroke clinic follow-up.
Source: Journal of Stroke and Cerebrovascular Diseases - June 21, 2023 Category: Neurology Authors: Darwish Alabyad, Manet Lemuel-Clarke, Marlyn Antwan, Laura Henriquez, Samir Belagaje, Srikant Rangaraju, Ashlee Mosley, Jacqueline Cabral, Teri Walczak, Moges Ido, Patricia Hashima, Rana Bayakly, Kathyrn Collins, Loretta Sutherly-Bhadsavle, Cynthia Brashe Source Type: research

A tale of two cities: A retrospective observational cohort study of the impact of COVID-19 on acute stroke presentation, timing, and outcomes
The purpose of this study was to identify the impact of COVID-19-related “shelter in place” restrictions on stroke metrics in two metropolitan Texas cities, Austin and San Antonio.
Source: Journal of Stroke and Cerebrovascular Diseases - July 26, 2023 Category: Neurology Authors: Gretchel Gealogo Brown, Razieh Foroughi, Sujani Bandela, Agnelio Cardentey, Kal L Clark, Adrienne N Dula Source Type: research

Falling stroke rates during COVID-19 pandemic at a Comprehensive Stroke Center: Cover title: Falling stroke rates during COVID-19
The novel human coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), began in Wuhan, China in December of 2019 and has led to a pandemic, accounting for more than 2.4 million worldwide infections and more than 160,000 deaths (as of April 20, 2020).1,2
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: J.E. Siegler, M.E. Heslin, L. Thau, A. Smith, T.G. Jovin Source Type: research

Retraction notice to "Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US" Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 4 (April), 2021: 105639
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
Source: Journal of Stroke and Cerebrovascular Diseases - July 11, 2021 Category: Neurology Authors: Daniel Friedlich, Tali Newman, Stephanie Bricker Tags: Retraction notice Source Type: research

Call to Action: SARS-CoV-2 and Cerebrovascular DisordErs (CASCADE)
The novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), now named coronavirus disease 2019 (COVID-19), may change the risk of stroke through an enhanced systemic inflammatory response, hypercoagulable state, and endothelial damage in the cerebrovascular system. Moreover, due to the current pandemic, some countries have prioritized health resources towards COVID-19 management, making it more challenging to appropriately care for other potentially disabling and fatal diseases such as stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - May 6, 2020 Category: Neurology Authors: Shahram Abootalebi, Benjamin M. Aertker, Mohammad Sobhan Andalibi, Negar Asdaghi, Ozlem Aykac, M. Reza Azarpazhooh, M. Cecilia Bahit, Kristian Barlinn, Hamidon Basri, Reza Bavarsad Shahripour, Anna Bersano, Jose Biller, Afshin Borhani-Haghighi, Robert D. Source Type: research

Acute ophthalmic artery occlusion in a Covid-19 patient on apixaban
We report a case of acute OAO in a young patient with a severe form of Covid-19 infection that was on therapeutic anticoagulation with apixaban for deep venous thrombosis (DVT).
Source: Journal of Stroke and Cerebrovascular Diseases - May 22, 2020 Category: Neurology Authors: Oana M. Dumitrascu, Oksana Volod, Swaraj Bose, Yao Wang, Val érie Biousse, Patrick D. Lyden Source Type: research

Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center
The novel human coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), began in Wuhan, China in December of 2019 and has led to a pandemic, accounting for more than 2.4 million worldwide infections and more than 160,000 deaths (as of April 20, 2020).1,2
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: J.E. Siegler, M.E. Heslin, L. Thau, A. Smith, T.G. Jovin Source Type: research

Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: A systematic review and meta-analysis
This systematic review and meta-analysis aimed to evaluate the impact of the coronavirus disease (COVID-19) pandemic on stroke care, including the number of stroke alerts/codes, number of reperfusions, and number of thrombectomies during the pandemic compared to those during the pre-pandemic period.
Source: Journal of Stroke and Cerebrovascular Diseases - July 21, 2020 Category: Neurology Authors: Julius July, Raymond Pranata Source Type: research

Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is responsible for an unprecedented worldwide pandemic that has severely impacted the United States. As the pandemic continues, a growing body of evidence suggests that infected patients may develop significant coagulopathy with resultant thromboembolic complications including deep vein thrombosis, pulmonary embolism, myocardial infarction, and ischemic stroke. However, this data is limited and comes from recent small case series and observational studies on stroke types, mechanisms, and outcomes.
Source: Journal of Stroke and Cerebrovascular Diseases - August 4, 2020 Category: Neurology Authors: Smit D. Patel, Ryan Kollar, Patrick Troy, Xianyuan Song, Mohammad Khaled, Augusto Parra, Mubashir Pervez Source Type: research

Letter to Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19
We read the article by Carneiro et al with great interest1. We have similar experiences at two downtown Los Angeles certified stroke centers with the use of intravenous tPA. However, there are concerning observations lately among COVID-19 patients who developed large vessel re-occlusions shortly after their original stroke symptoms were aborted by intravenous tPA.
Source: Journal of Stroke and Cerebrovascular Diseases - April 2, 2021 Category: Neurology Authors: Angelo Jimenez, Arvind Ravinutala, Jonathan Eskenazi, Prissilla Xu, Antonio Liu Source Type: research

Telestroke Across the Continuum of Care: Lessons from the COVID-19 Pandemic
While use of telemedicine to guide emergent treatment of ischemic stroke is well established, the COVID-19 pandemic motivated the rapid expansion of care via telemedicine to provide consistent care while reducing patient and provider exposure and preserving personal protective equipment. Temporary changes in re-imbursement, inclusion of home office and patient home environments, and increased access to telehealth technologies by patients, health care staff and health care facilities were key to provide an environment for creative and consistent high-quality stroke care.
Source: Journal of Stroke and Cerebrovascular Diseases - April 8, 2021 Category: Neurology Authors: Amy K. Guzik, Sheryl Martin-Schild, Prasanna Tadi, Sherita N. Chapman, Sami Al Kasab, Sharyl R. Martini, Brett C. Meyer, Bart M. Demaerschalk, Marcella A. Wozniak, Andrew M. Southerland Source Type: research

Consideration Needed for early Anticoagulation Following Intravenous tPA in Patients with COVID-19
We read the article by Carneiro et al with great interest.1 We have similar experiences at two downtown Los Angeles certified stroke centers with the use of intravenous tPA. However, there are concerning observations lately among COVID-19 patients who developed large vessel re-occlusions shortly after their original stroke symptoms were aborted by intravenous tPA.
Source: Journal of Stroke and Cerebrovascular Diseases - April 2, 2021 Category: Neurology Authors: Angelo Jimenez, Arvind Ravinutala, Jonathan Eskenazi, Prissilla Xu, Antonio Liu Tags: Letter to the Editor Source Type: research

Letter to the Editor Regarding ‘A neonatal case of cerebral venous sinus thrombosis with intrauterine onset after COVID19 infection during pregnancy: cause or coincidence?’
We read with interest the article by Ozdil et al. about a three day-old female neonate who was diagnosed with venous sinus thrombosis (VST) which was complicated by a subacute, partial ischemic stroke in the territory of the right middle cerebral artery.1 The age of the stroke was estimated at 14-28 days before birth.1 Because the mother suffered a mild coronvirus disease-19 (COVID-19) infection during the initial weeks of the third trimester (gestational weeks 27-30), VST in the fetus was causally related to the severe, acute respiratory syndrome-coronavirus type-2 (SARS-CoV-2) infection of the mother.
Source: Journal of Stroke and Cerebrovascular Diseases - April 7, 2023 Category: Neurology Authors: Josef Finsterer Tags: Letter to the Editor Source Type: research

Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
An outbreak of an acute respiratory illness of unknown cause started in Wuhan, Hubei province, China on December 12, 2019.1,2 A new strain of coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in these patients. Subsequently, the identified acute respiratory illness was named coronavirus disease 2019 (COVID-19). Soon thereafter, the COVID-19 epidemic in China became a pandemic with a significant burden on healthcare and the world-wide economy. SARS-CoV-2 has been shown to be a distinct class of the beta coronaviruses (Beta-CoVs) with a 79.5% gene sequence homology to the severe ...
Source: Journal of Stroke and Cerebrovascular Diseases - May 10, 2020 Category: Neurology Authors: Afshin A. Divani, Sasan Andalib, Mario Di Napoli, Simona Lattanzi, M. Shazam Hussain, Jos é Biller, Louise D. McCullough, M. Reza Azarpazhooh, Alina Seletska, Stephan A. Mayer, Michel Torbey Tags: Review Article Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13